Anuh Pharma News and Updates

Name: Latest research reports of Anuh Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Anuh Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Keep track of all breaking news on Anuh Pharma from all sources in a single place.

Anuh Pharma Ltd.

05 May 2026

82.57

-1.39%

Anuh Pharma up 7% on receiving WHO prequalification for anti-malarial API

Business Standard

The buying on the counter came after the company received World Health Organization (WHO) prequalification approval for Amodiaquine Hydrochloride USP

Anuh Pharma Ltd. is trading above its 200 day SMA of 79.6

Anuh Pharma Ltd.

30 May 2016

82.57

-1.39%

Results Overview- Below ests; Disappointment on all counts; EDQM ruli

Buy: Anuh Pharma Ltd.

Motilal Oswal

In its bid to add new high value products, Anuh has been developing new APIs which have recently gone off patent (post 2014 or which are likely to go off patent in the future). These new APIs will have much higher margins compared to the existing basket. Anuh currently has 20 products in the pipeline of which 4 would be launched in...

Anuh Pharma Ltd. is trading below its 30 day SMA of 88.2

Is Anuh Pharma Ltd. worth buying?

235 Votes:

Buy 72.77%

Sell 11.06%

Hold 16.17%